1105 W. Park Ave, Suite 3A
Libertyville, IL 60048
Most people are surprised to learn that one American dies every hour from oral cancer; a death rate that has remained virtually unchanged for more than 40 years. In fact, recent statistics published by the American Cancer Society indicate that while the incidence and death rates for cancers overall has decreased, the incidence of oral cancer has increased by 5.5% and the death rate has increased by 1.5%
Oral cancer is far too often discovered in late stage development, the primary reason for the consistently high death rate. Oral cancer treatment often results in disfiguring effects on patients, and can seriously compromise their quality of life. Early detection and diagnosis can make a tremendous difference in life expectancy; oral cancer is 90% curable when found in its early stages. Unfortunately, 70% of oral cancers are diagnosed in the late stages, III and IV, leading to a five-year survival rate of 57%.
is an oral lesion identification and marking system that is used as an adjunct to the conventional head and neck examination. It is comprised of a chemiluminescent light source (ViziLite) to improve the identification of lesions and a blue phenothiazine dye to mark those lesions identified by ViziLite. ViziLitePlus with TBlue is designed to be used in a patient population at increased risk for oral cancer.
In clinical trials involving 13,000 female patients, abnormal squamous epithelium in the cervical complex appears distinctly white after washing the cervix with a dilute acetic acid solution and viewed under chemiluminescent light (Speculite®). Similarly, examination of the oral cavity under chemiluminescent light (ViziLite) after rinsing with a dilute acetic acid solution, abnormal squamous epithelium tissue will appear distinctly white. LumenoscopyTM has demonstrated in numerous studies to improve the ability to visualize mucosal lesions and initially identify clinically suspicious lesions.
Oral cancer is one of the most curable diseases when it's caught early. That's why the ViziLite Plus exam has been developed. ViziLite Plus uses technology that has proven successful in identifying soft tissue abnormalities in other areas of the body. A ViziLite Plus exam is particularly important if you are at increased risk for developing oral cancer.
The ViziLite Plus exam can help your dentist or hygienist identify abnormal tissue, that might develop into oral cancer.
An annual ViziLite Plus exam, in combination with a regular visual examination, provides a comprehensive oral screening procedure for patients at increased risk for oral cancer. The ViziLite Plus exam is painless and fast, and could help save your life.
ViziLite Plus is performed immediately following a regular visual examination
First, you will be instructed to rinse with a cleansing solution
Next, the overhead lighting will be dimmed.
Then, your dental professional will examine your mouth using ViziLite Plus, a specially designed light technology.